| Q28537708 | A quantitative high-resolution genetic profile rapidly identifies sequence determinants of hepatitis C viral fitness and drug sensitivity |
| Q35082721 | A screen for genetic suppressor elements of hepatitis C virus identifies a supercharged protein inhibitor of viral replication |
| Q28536780 | Artemisinin analogues as potent inhibitors of in vitro hepatitis C virus replication |
| Q39219026 | Combinations of lambda interferon with direct-acting antiviral agents are highly efficient in suppressing hepatitis C virus replication |
| Q35105904 | Computational study on the inhibitor binding mode and allosteric regulation mechanism in hepatitis C virus NS3/4A protein |
| Q36531731 | Direct-acting Antiviral Agents Resistance-associated Polymorphisms in Chinese Treatment-naïve Patients Infected with Genotype 1b Hepatitis C Virus |
| Q40685694 | Exploring resistance mechanisms of HCV NS3/4A protease mutations to MK5172: insight from molecular dynamics simulations and free energy calculations |
| Q34485877 | Future research and collaboration: the "SINERGIE" project on HCV (South Italian Network for Rational Guidelines and International Epidemiology). |
| Q28540849 | Genetic characterization of hepatitis C virus in long-term RNA replication using Li23 cell culture systems |
| Q34008754 | Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy |
| Q39731249 | Hepatitis C virus protease inhibitors: patent highlight |
| Q38156875 | Hepatitis C virus resistance to new specifically-targeted antiviral therapy: A public health perspective. |
| Q41887493 | In vitro systems for the study of hepatitis C virus infection |
| Q41259954 | Molecular characterization of hepatitis C virus for determination of subtypes and detection of resistance mutations to protease inhibitors in a group of intravenous drug users co-infected with HIV. |
| Q42988260 | Molecular modeling comparison of the performance of NS5b polymerase inhibitor (PSI-7977) on prevalent HCV genotypes |
| Q44781142 | Multiple effects of toxins isolated from Crotalus durissus terrificus on the hepatitis C virus life cycle |
| Q36404194 | Neutralization interfering antibodies: a "novel" example of humoral immune dysfunction facilitating viral escape? |
| Q56957250 | Quasispecies and Drug Resistance |
| Q31129723 | Replication vesicles are load- and choke-points in the hepatitis C virus lifecycle |
| Q26777408 | Resistance of Hepatitis C Virus to Inhibitors: Complexity and Clinical Implications |
| Q38113079 | The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection |
| Q26740219 | Treatment of chronic hepatitis C with direct-acting antivirals: The role of resistance |